Stable Pharmaceutical formulation, parenteral, the Antibody against the Peptide Amyloid beta (Abeta); and use of the Formulation for the treatment of Alzheimer's disease.

摘要

The present invention relates to a stable pharmaceutical parenteral formulation of an antibody, antibody molecule, a mixture of antibodies and/or a mixture of antibody molecules against the amyloid-beta peptide (Abeta) and a process for the preparation. Furthermore, corresponding uses are described.